Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 200.80
Bid: 201.40
Ask: 201.80
Change: -2.60 (-1.28%)
Spread: 0.40 (0.199%)
Open: 207.00
High: 207.60
Low: 200.80
Prev. Close: 203.40
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Dec 2021 17:00

RNS Number : 4778V
Direct Line Insurance Group PLC
13 December 2021
 

DIRECT LINE INSURANCE GROUP PLC ("DLG")

 

TRANSACTIONS IN SHARES BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMRS")

 

13 DECEMBER 2021

 

Following the appointment of Ash Jokhoo as Chief Information Officer on 15 November 2021, awards have been made to Ash under the DLG 2020 Long Term Incentive Plan (the "LTIP") and the Restricted Share Plan ("RSP") to compensate him for remuneration arrangements forfeited on leaving his former employer. Performance conditions do not apply to the RSP awards.

 

Following the appointment of Aurore Lecanon as Chief Risk Officer on 22 November 2021, awards have been made to Aurore under the DLG RSP to compensate her for remuneration arrangements forfeited on leaving her former employer. Performance conditions do not apply to these awards.

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014(as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Ash Jokhoo

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Information Officer / PDMR

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Direct Line Insurance Group plc

b)

 

LEI

 

 

213800FF2R23ALJQOP04

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 10/11 pence ("Shares")

 

 

 

GB00BY9D0Y18

b)

 

Nature of the transaction

 

 

(i) Award of three years nil cost options under the Direct Line Insurance Group plc 2020 Long Term Incentive Plan. The award represents the regular 2021 award, has a total face value of 125% of annual base salary and is subject to the same performance conditions as awards made to DLG's PDMRS earlier in the year (except that Total Shareholder Return will be measured over the three years commencing on the date of grant).

(ii) Award of nil cost options under the Restricted Share Plan.

(iii) Award of nil cost options under the Restricted Share Plan.

 

c)

 

Price(s) and volume(s)

 

 

 

Price

Volume

Nil cost options

183,150

Nil cost options

123,076

Nil cost options

146,153

d)

 

Aggregated information

- Aggregated volume

- Price

 

452,379

N/A

 

e)

 

Date of the transaction

 

 

9 December 2021

f)

 

Place of the transaction

 

 

Off market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Aurore Lecanon

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Risk Officer / PDMR

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Direct Line Insurance Group plc

b)

 

LEI

 

 

213800FF2R23ALJQOP04

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 10 10/11 pence ("Shares")

 

 

 

GB00BY9D0Y18

 

b)

 

Nature of the transaction

 

 

Award of nil cost options under the Restricted Share Plan. The award vests in three tranches.

 

c)

 

Price(s) and volume(s)

 

 

 

Price

Volume

Nil cost options

82,739

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

82,739

N/A

 

e)

 

Date of the transaction

 

 

9 December 2021

f)

 

Place of the transaction

 

 

Off market

 

 

For any enquiries relating to this announcement, please contact:

 

Roger Clifton

Company Secretary

Email: Roger.Clifton@directlinegroup.co.uk

 

 

LEI: 213800FF2R23ALJQOP04

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZXLFFFLLZFBK
Date   Source Headline
7th Sep 20237:00 amRNSSale of Brokered Commercial Insurance Business
7th Sep 20237:00 amRNSHalf-Year Report 2023
1st Sep 20237:00 amRNSStatement re past business review
31st Aug 20236:00 pmRNSDirectorate Change
30th Aug 20234:00 pmRNSDirector/PDMR Shareholding
30th Aug 20237:00 amRNSAppointment of CEO
28th Jul 20234:00 pmRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSResponse to press coverage
28th Jun 20232:00 pmRNSDirector/PDMR Shareholding
1st Jun 20235:00 pmRNSNotice of Results
31st May 20233:00 pmRNSDirector/PDMR Shareholding
30th May 20236:30 pmRNSDirector/PDMR Shareholding
30th May 20235:30 pmRNSDirector/PDMR Shareholding
12th May 20233:30 pmRNSDirector/PDMR Shareholding
9th May 20233:00 pmRNSResult of AGM
9th May 20237:00 amRNSTrading Update for Q1 2023
28th Apr 20233:00 pmRNSDirector/PDMR Shareholding
25th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20234:00 pmRNSHolding(s) in Company
3rd Apr 20234:15 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:00 pmRNSNotice of 2023 AGM
31st Mar 20233:00 pmRNSHolding(s) in Company
31st Mar 20232:30 pmRNS2022 Solvency and Financial Condition Report
30th Mar 20233:00 pmRNSAppointment to Board Committees
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
24th Mar 20239:30 amRNS2022 Annual Report and Accounts
20th Mar 20234:00 pmRNSHolding(s) in Company
14th Mar 20236:30 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSPreliminary Results year ended 31 December 2022
10th Mar 202310:15 amRNSDirector Declaration
1st Mar 20235:00 pmRNSHolding(s) in Company
28th Feb 20234:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20236:15 pmRNSHolding(s) in Company
17th Feb 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSNotice of 2022 preliminary results
30th Jan 20233:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSDirect Line Group executes strategic reinsurance
16th Jan 20236:00 pmRNSHolding(s) in Company
12th Jan 20233:00 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading Update
29th Dec 202212:00 pmRNSDirector/PDMR Shareholding
13th Dec 20224:00 pmRNSHolding(s) in Company
12th Dec 20227:00 amRNSIFRS 17 update
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
18th Nov 20224:00 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSTrading Update for Q3 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.